Open AccessA better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
Author(s) -
Ichiro Ikushima,
Yasuhiko Iryo,
Yasuyuki Yamashita
Publication year - 2011
Publication title -
medical devices evidence and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.482
H-Index - 30
ISSN - 1179-1470
DOI - 10.2147/mder.s21629
Subject(s) - cilostazol , ticlopidine , restenosis , medicine , stent , hazard ratio , proportional hazards model , cardiology , femoral artery , surgery , aspirin , clopidogrel , confidence interval
The purpose of this study was to assess the preventive effect of cilostazol on in-stent restenosis in patients after superficial femoral artery (SFA) stent placement.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom